Maryland recently faced a setback as Moody’s changed its outlook on the state’s credit rating to negative from stable. This decision was primarily driven by the depletion of the state’s general fund surplus, which raised concerns about future structural imbalances. Despite affirming the state’s issuer and general obligation bond ratings at Aaa, Moody’s pointed out
0 Comments
In a recent announcement, the Food and Drug Administration granted approval for Moderna’s vaccine for respiratory syncytial virus (RSV) for adults aged 60 and older. This marks a significant milestone for Moderna, as it diversifies its product portfolio beyond its Covid jab, which has seen a decrease in demand. The decision to approve Moderna’s RSV
0 Comments